Tsukuba, Japan

Tetsuhiko Yoshida

USPTO Granted Patents = 58 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 163(Granted Patents)

Forward Citations (Not Self Cited) = 154(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Aichi, JP (2010)
  • Nagoya, JP (2002 - 2012)
  • Ibaraki, JP (2016 - 2022)
  • Ibaraki-ken, JP (2022)
  • Tokyo, JP (2022)
  • Tsukuba, JP (2013 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
58 patents (USPTO):Explore Patents

Title: Contributions of Tetsuhiko Yoshida in the Field of Biomedicine

Introduction: Tetsuhiko Yoshida, a prominent inventor based in Tsukuba, Japan, is renowned for his significant contributions to biomedicine, particularly through his work on RNA-based therapeutics. With an impressive portfolio of 56 patents, he has made substantial advancements in the understanding and treatment of viral diseases.

Latest Patents: Among his latest innovations, Yoshida has developed siRNA targeting SARS-CoV-2. This siRNA is designed to suppress the proliferation of the coronavirus and includes both a sense strand and an antisense strand. The sense strand specifically comprises a target sequence of 19 to 23 bases, with the 5' terminal base being guanine or cytosine, along with an overhang on the 3′ terminal. The antisense strand complements the target and also features a 3′ terminal overhang. Notably, part of the target sequence encodes the signal peptide region of the spike protein of SARS-CoV-2. Another groundbreaking invention by Yoshida is an antitumor peptide, which offers potential therapeutic applications against tumors.

Career Highlights: Tetsuhiko Yoshida has built a commendable career in both corporate and academic settings. He has worked with Toagosei Company, Ltd., where he applied his innovative skills to enhance biopharmaceutical developments. Additionally, he is associated with the National University Corporation Nagoya University, contributing to research and development that bridges scientific inquiry and practical application.

Collaborations: Throughout his career, Yoshida has collaborated with several esteemed colleagues, including Nahoko Baileykobayashi and Nahoko Kobayashi. These partnerships have fostered a collaborative environment that encourages the pursuit of groundbreaking innovations in biotechnology.

Conclusion: Tetsuhiko Yoshida's work exemplifies the vital role of inventors in advancing healthcare through innovative solutions. His patents not only reflect his expertise but also contribute to the broader understanding of disease mechanisms and the development of targeted therapies. As his career continues to evolve, Yoshida remains a key figure in the realm of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…